ARGO BLOCKCHAIN PLC (ARBK)

US0401261047 - ADR

0.6255  -0.03 (-4.15%)

Premarket: 0.635 +0.01 (+1.52%)

Fundamental Rating

2

ARBK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 280 industry peers in the Software industry. ARBK has a bad profitability rating. Also its financial health evaluation is rather negative. ARBK is quite expensive at the moment. It does show a decent growth rate.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

ARBK had negative earnings in the past year.
ARBK had a positive operating cash flow in the past year.
In multiple years ARBK reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ARBK reported negative operating cash flow in multiple years.

1.2 Ratios

ARBK's Return On Assets of -154.58% is on the low side compared to the rest of the industry. ARBK is outperformed by 94.53% of its industry peers.
Industry RankSector Rank
ROA -154.58%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ARBK has a Gross Margin of 12.54%. This is amonst the worse of the industry: ARBK underperforms 88.69% of its industry peers.
In the last couple of years the Gross Margin of ARBK has declined.
ARBK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.4%
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

ARBK does not have a ROIC to compare to the WACC, probably because it is not profitable.
ARBK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

ARBK has an Altman-Z score of -8.18. This is a bad value and indicates that ARBK is not financially healthy and even has some risk of bankruptcy.
ARBK has a Altman-Z score of -8.18. This is amonst the worse of the industry: ARBK underperforms 90.15% of its industry peers.
ARBK has a debt to FCF ratio of 5.62. This is a neutral value as ARBK would need 5.62 years to pay back of all of its debts.
ARBK has a Debt to FCF ratio of 5.62. This is comparable to the rest of the industry: ARBK outperforms 54.74% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.62
Altman-Z -8.18
ROIC/WACCN/A
WACC17.87%

2.3 Liquidity

A Current Ratio of 0.43 indicates that ARBK may have some problems paying its short term obligations.
ARBK's Current ratio of 0.43 is on the low side compared to the rest of the industry. ARBK is outperformed by 94.89% of its industry peers.
A Quick Ratio of 0.43 indicates that ARBK may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.43, ARBK is doing worse than 94.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.43

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 85.61% over the past year.
ARBK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.70%.
Measured over the past years, ARBK shows a very strong growth in Revenue. The Revenue has been growing by 131.25% on average per year.
EPS 1Y (TTM)85.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-221.73%
Revenue 1Y (TTM)-13.7%
Revenue growth 3Y28.27%
Revenue growth 5Y131.25%
Sales Q2Q%-1.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
Based on estimates for the next years, ARBK will show a very strong growth in Revenue. The Revenue will grow by 47.84% on average per year.
EPS Next Y97%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-7.51%
Revenue Next 2Y59.65%
Revenue Next 3Y47.84%
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ARBK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ARBK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ARBK is valued cheaper than 87.96% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ARBK indicates a rather cheap valuation: ARBK is cheaper than 99.27% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.97
EV/EBITDA 14.57

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ARBK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARGO BLOCKCHAIN PLC

NASDAQ:ARBK (1/8/2025, 8:00:00 PM)

Premarket: 0.635 +0.01 (+1.52%)

0.6255

-0.03 (-4.15%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-28 2024-08-28/bmo
Earnings (Next)N/A N/A
Inst Owners11.34%
Inst Owner Change0%
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap39.80M
Analysts40
Price Target1.22 (95.04%)
Short Float %0.24%
Short Ratio1.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.76%
PT rev (3m)62.18%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.71
P/FCF 4.97
P/OCF 5.09
P/B N/A
P/tB N/A
EV/EBITDA 14.57
EPS(TTM)-0.88
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.13
FCFY20.11%
OCF(TTM)0.12
OCFY19.63%
SpS0.88
BVpS-0.32
TBVpS-0.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -154.58%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.54%
FCFM 14.34%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-28.4%
GM growth 5YN/A
F-Score5
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.62
Debt/EBITDA 7.07
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion 140.96%
Profit Quality N/A
Current Ratio 0.43
Quick Ratio 0.43
Altman-Z -8.18
F-Score5
WACC17.87%
ROIC/WACCN/A
Cap/Depr(3y)492.04%
Cap/Depr(5y)436.52%
Cap/Sales(3y)122.96%
Cap/Sales(5y)110.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-221.73%
EPS Next Y97%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.7%
Revenue growth 3Y28.27%
Revenue growth 5Y131.25%
Sales Q2Q%-1.1%
Revenue Next Year-7.51%
Revenue Next 2Y59.65%
Revenue Next 3Y47.84%
Revenue Next 5YN/A
EBIT growth 1Y82.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year142.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y104.22%
FCF growth 3Y57.17%
FCF growth 5YN/A
OCF growth 1Y981.98%
OCF growth 3Y8.67%
OCF growth 5YN/A